MR imaging of carotid plaque composition during lipid-lowering therapy a prospective assessment of effect and time course.

[1]  S. Cramer,et al.  Predictors of Surface Disruption with MR Imaging in Asymptomatic Carotid Artery Stenosis , 2010, American Journal of Neuroradiology.

[2]  Chun Yuan,et al.  Effect of rosuvastatin therapy on carotid plaque morphology and composition in moderately hypercholesterolemic patients: a high-resolution magnetic resonance imaging trial. , 2008, American heart journal.

[3]  Luni Chen,et al.  Simvastatin with or without ezetimibe in familial hypercholesterolemia. , 2008, The New England journal of medicine.

[4]  S. Marcovina,et al.  Effects of adding extended-release niacin and colesevelam to statin therapy on lipid levels in subjects with atherosclerotic disease. , 2007, Journal of clinical lipidology.

[5]  Fei Liu,et al.  Magnetic Resonance Imaging of Carotid Atherosclerosis: Plaque Analysis , 2007, Topics in magnetic resonance imaging : TMRI.

[6]  C. Yuan,et al.  Testing the hypothesis of atherosclerotic plaque lipid depletion during lipid therapy by magnetic resonance imaging: study design of Carotid Plaque Composition Study. , 2007, American heart journal.

[7]  Diederick E Grobbee,et al.  Effect of rosuvastatin on progression of carotid intima-media thickness in low-risk individuals with subclinical atherosclerosis: the METEOR Trial. , 2007, JAMA.

[8]  G. Moneta,et al.  Association Between Carotid Plaque Characteristics and Subsequent Ischemic Cerebrovascular Events: A Prospective Assessment With MRI—Initial Results , 2007 .

[9]  R. Cury,et al.  Intra‐ and interreader reproducibility of magnetic resonance imaging for quantifying the lipid‐rich necrotic core is improved with gadolinium contrast enhancement , 2006, Journal of magnetic resonance imaging : JMRI.

[10]  Chun Yuan,et al.  In Vivo Quantitative Measurement of Intact Fibrous Cap and Lipid-Rich Necrotic Core Size in Atherosclerotic Carotid Plaque: Comparison of High-Resolution, Contrast-Enhanced Magnetic Resonance Imaging and Histology , 2005, Circulation.

[11]  V. Fuster,et al.  Effects of aggressive versus conventional lipid-lowering therapy by simvastatin on human atherosclerotic lesions: a prospective, randomized, double-blind trial with high-resolution magnetic resonance imaging. , 2005, Journal of the American College of Cardiology.

[12]  W S Kerwin,et al.  Carotid Plaque Composition Differs Between Ethno-Racial Groups: An MRI Pilot Study Comparing Mainland Chinese and American Caucasian Patients , 2005, Arteriosclerosis, thrombosis, and vascular biology.

[13]  Alfons G H Kessels,et al.  Assessment of human atherosclerotic carotid plaque components with multisequence MR imaging: initial experience. , 2005, Radiology.

[14]  Brian K Rutt,et al.  Quantitative assessment of carotid plaque composition using multicontrast MRI and registered histology , 2003, Magnetic resonance in medicine.

[15]  Chun Yuan,et al.  In vivo accuracy of multisequence MR imaging for identifying unstable fibrous caps in advanced human carotid plaques , 2003, Journal of magnetic resonance imaging : JMRI.

[16]  V. Fuster,et al.  Lipid Lowering by Simvastatin Induces Regression of Human Atherosclerotic Lesions: Two Years’ Follow-Up by High-Resolution Noninvasive Magnetic Resonance Imaging , 2002, Circulation.

[17]  Chun Yuan,et al.  Classification of Human Carotid Atherosclerotic Lesions With In Vivo Multicontrast Magnetic Resonance Imaging , 2002, Circulation.

[18]  W S Kerwin,et al.  In Vivo Accuracy of Multispectral Magnetic Resonance Imaging for Identifying Lipid-Rich Necrotic Cores and Intraplaque Hemorrhage in Advanced Human Carotid Plaques , 2001, Circulation.

[19]  K R Maravilla,et al.  Effects of Prolonged Intensive Lipid-Lowering Therapy on the Characteristics of Carotid Atherosclerotic Plaques In Vivo by MRI: A Case-Control Study , 2001, Arteriosclerosis, thrombosis, and vascular biology.

[20]  P. Shah,et al.  Pravastatin Treatment Increases Collagen Content and Decreases Lipid Content, Inflammation, Metalloproteinases, and Cell Death in Human Carotid Plaques: Implications for Plaque Stabilization , 2001, Circulation.

[21]  Loyd,et al.  SIMVASTATIN AND NIACIN , ANTIOXIDANT VITAMINS , OR THE COMBINATION FOR THE PREVENTION OF CORONARY DISEASE , 2001 .

[22]  V. Fuster,et al.  The diagnostic accuracy of ex vivo MRI for human atherosclerotic plaque characterization. , 1999, Arteriosclerosis, thrombosis, and vascular biology.

[23]  E. Braunwald,et al.  Clinical trials in cardiovascular disease : a companion to Braunwald's heart disease , 1999 .

[24]  H. Brown.  Lipid-lowering therapy , 2011 .

[25]  M J Davies,et al.  Stability and instability: two faces of coronary atherosclerosis. The Paul Dudley White Lecture 1995. , 1996, Circulation.

[26]  Richard T. Lee,et al.  Macrophages and atherosclerotic plaque stability , 1996, Current opinion in lipidology.

[27]  C Yuan,et al.  Surface coil phased arrays for high‐resolution imaging of the carotid arteries , 1996, Journal of magnetic resonance imaging : JMRI.

[28]  V. Fuster,et al.  Macrophage Infiltration in Acute Coronary Syndromes: Implications for Plaque Rupture , 1994, Circulation.

[29]  A. Becker,et al.  Site of intimal rupture or erosion of thrombosed coronary atherosclerotic plaques is characterized by an inflammatory process irrespective of the dominant plaque morphology. , 1994, Circulation.

[30]  M. Davies,et al.  Risk of thrombosis in human atherosclerotic plaques: role of extracellular lipid, macrophage, and smooth muscle cell content. , 1993, British heart journal.

[31]  M. Bond,et al.  Physicochemical and histological changes in the arterial wall of nonhuman primates during progression and regression of atherosclerosis. , 1984, The Journal of clinical investigation.

[32]  M. Bond,et al.  A study of atherosclerosis regression in Macaca mulatta. IV. Changes in coronary arteries from animals with atherosclerosis induced for 19 months and then regressed for 24 or 48 months at plasma cholesterol concentrations of 300 or 200 mg/dl. , 1981, Experimental and molecular pathology.

[33]  M. Bond,et al.  A study of atherosclerosis regression in Macaca mulatta. I. Design of experiment and lesion induction. , 1979, Experimental and molecular pathology.

[34]  M. Armstrong,et al.  Arterial Fibrous Proteins in Cynomolgus Monkeys after Atherogenic and Regression Diets , 1975, Circulation research.

[35]  M. Armstrong,et al.  Lipid Depletion in Atheromatous Coronary Arteries in Rhesus Monkeys after Regression Diets , 1972, Circulation research.